Trimethylammonium

Trimethylammonium

SCHEMBL7802299

CCNc1ccc(Cl)cc1.CN(C)C

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.49
MAPT P10636 3/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
RAB9A P51151 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
RECQL P46063 1/20 0.43
LMNA P02545 3/20 0.42
ADRA2A P08913 2/20 0.42
ADRA2B P18089 2/20 0.42
ADRA2C P18825 2/20 0.42
P2RX3 P56373 1/20 0.41
ALDH1A1 P00352 3/20 0.41
GAA P10253 1/20 0.41
NPC1 O15118 2/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL632439 0.93 CNR2 (0.48) CNR2MAPTMEN1KMT2ARAB9A
Hydrochloric Acid SCHEMBL1924678 0.91 CNR2 (0.47) CNR2MAPTMEN1KMT2ARAB9A
SCHEMBL12355492 0.81 P2RX3 (0.48) P2RX3ALDH1A1GAA
SCHEMBL7801499 0.80 ALDH1A1 (0.55) CNR2MAPTTSHRMEN1KMT2A
SCHEMBL526383 0.80 MAPT (0.58) MAPTTSHRMEN1KMT2ARECQL
Ammonia Solution, Strong SCHEMBL28486254 0.77 MAPT (0.56) MAPTTSHRMEN1KMT2ARECQL
Hydrochloric Acid SCHEMBL9181167 0.77 MAPT (0.56) MAPTTSHRMEN1KMT2ARECQL
Ammonia Solution, Strong SCHEMBL28483632 0.77 MAPT (0.56) MAPTTSHRMEN1KMT2ARECQL
SCHEMBL15478385 0.76 CNR2 (0.43) CNR2MAPTMEN1KMT2ARAB9A
SCHEMBL1801536 0.74 NR1I2 (0.56) CNR2MAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC CNR2 3039/4885MAPT 95/4885TSHR 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.